Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000692683 | SCV000820519 | likely benign | Episodic ataxia type 2; Developmental and epileptic encephalopathy, 42 | 2023-07-17 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV001289290 | SCV001477017 | uncertain significance | not provided | 2020-04-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002345374 | SCV002647045 | uncertain significance | Inborn genetic diseases | 2017-07-05 | criteria provided, single submitter | clinical testing | The p.R1780Q variant (also known as c.5339G>A), located in coding exon 35 of the CACNA1A gene, results from a G to A substitution at nucleotide position 5339. The arginine at codon 1780 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |